BioCryst Pharmaceuticals, Inc. (BCRX)
7.525
-0.10
(-1.38%)
USD |
NASDAQ |
Nov 10, 16:00
7.525
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Cash from Operations (Annual) : 329.88M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 329.88M |
| December 31, 2024 | -52.02M |
| December 31, 2023 | -95.14M |
| December 31, 2022 | -161.85M |
| December 31, 2021 | -142.16M |
| December 31, 2020 | -137.22M |
| December 31, 2019 | -89.58M |
| December 31, 2018 | -92.56M |
| December 31, 2017 | -41.14M |
| December 31, 2016 | -53.44M |
| December 31, 2015 | -13.12M |
| December 31, 2014 | -38.55M |
| December 31, 2013 | -26.53M |
| December 31, 2012 | -37.40M |
| December 31, 2011 | -32.25M |
| December 31, 2010 | -28.55M |
| Date | Value |
|---|---|
| December 31, 2009 | -16.22M |
| December 31, 2008 | -20.87M |
| December 31, 2007 | -25.00M |
| December 31, 2006 | -15.21M |
| December 31, 2005 | -23.35M |
| December 31, 2004 | -18.15M |
| December 31, 2003 | -11.20M |
| December 31, 2002 | -16.36M |
| December 31, 2001 | -10.16M |
| December 31, 2000 | -3.178M |
| December 31, 1999 | -4.918M |
| December 31, 1998 | -4.197M |
| December 31, 1997 | -10.30M |
| December 31, 1996 | -6.821M |
| December 31, 1995 | -7.676M |
| December 31, 1994 | -6.515M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Amgen, Inc. | 9.958B |
| Halozyme Therapeutics, Inc. | 651.56M |
| Neurocrine Biosciences, Inc. | 782.70M |
| Agenus, Inc. | -77.20M |
| Anika Therapeutics, Inc. | 11.19M |